|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Green tea and the risk of gastric cancer: Epidemiological evidence显示文摘Gastric cancer (GC) is one of the leading causes of cancer death in the world. Numerous efforts are being made to find chemoprotective agents able to reduce its risk. Amongst these, green tea has been reported to have a protective effect against stomach cancer. This article aims to critically evaluate all epidemiological studies reporting an association between green tea consumption and GC risk. MEDLINE, EBSCOHOST and Google Scholar were used to search for clinical trials of green tea and its correlation to stomach cancer. Studies include cohort and case-control studies. Outcome of interests are inverse association, no association, and positive association. Seventeen epidemiologic studies were reviewed. Eleven studies were conducted in Japan, five in China, and one with Japanese descendent in Hawaii. Ten case-control studies and seven cohortstudies were included. The relative risks or odds ratio of GC for the highest level of green tea consumption was compared. Seven studies suggested no association, eight an inverse association, and one a positive association. One study had shown a significantly lowered GC risk when tea was served warm to cold. Another study also showed a significantly risk with lukewarm tea. All studies that analyzed men and women separately have suggested a reduced risk in women than in men, albeit no significant difference. This review demonstrates that there is insufficient information to support green tea consumption reduces the risk of GC. More studies on the subject matter are warranted. | I-Chun Hou Saral Amarnani Mok T Chong Anupam Bishayee | 2013 | World Journal of Gastroenterology2013，19，24： | 8 |
| 2 | Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer显示文摘 | Mok T S Wu Y L Yu C J | 2009 | J ClinOneol2009，27，30： | 1 |
| 3 | The effect of time,temperature and storage device on umbilical cord blood gas and lactate measurement: a randomized controlled trial显示文摘 | White CR Mok T Doherty DA | 2012 | J Matern Fetal Neonatal Med2012，25，6： | 1 |
| 4 | Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘 | MOK T S WU Y L THONGPRASERT S | 2009 | N Engl J Med2009，361，10： | 1 |
| 5 | Management of non-small-cell lung cancer: recent developments显示文摘 | Reck M Heigener DF Mok T | 2013 | Lancet2013，382，9893： | 1 |
| 6 | Bronchial epithelial cells are rendered insensitive to glucocorticoid transactivation by transforming growth factor-β1显示文摘 | Keenan C R Mok J S Harris T | 2014 | Respir Res2014，15，1： | 1 |
| 7 | Management of non-small eell Lung eancer : recent developments 显示文摘 | Reek M Heigener DF Mok T | 2013 | Lancet2013，382，9893： | 1 |
| 8 | A sub-1-V 15 ppm/℃ CMOS bandgap voltage reference without requiring low threshold voltage device显示文摘 | Leung K N Mok P K T | 2002 | IEEE Journal of Solid-state Circuits2002，37，4： | 1 |
| 9 | Gefitinib versus doeetaxel in previously treated non-smalbeell lung cancer(INTEREST): arandomised phase Ⅲ trial 显示文摘 | Kim ES Hirsh V Mok T | 2008 | Lancet2008，372，9652： | 1 |
| 10 | Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘 | Mok T S Wu Y L Thongprasert S | 2009 | N Engl J Med2009，361，10： | 1 |
| 11 | Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST):a randomized phase Ⅲ trial显示文摘 | Kim ES Hirsh V Mok T | | 0，，9652： | 1 |
| 12 | First-line crizotinib versus chemotherapy in ALK-positive lung cancer显示文摘 | Solomon BJ Mok T Kim DW | 2014 | N Engl I Med2014，371，23： | 1 |
| 13 | ASCEND-2: A single-arm, open-label, multicenter phase II study of ceritinib in adult patients (pts) with ALK- rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ)显示文摘 | Mok T Spigel D Felip E | 2015 | J Clin Oncol2015，33，： | 1 |
| 14 | A capacitor- free CMOS low-dropout regulator with damping- factor-control frequency compensation显示文摘 | Leung K N Mok P K T | 2003 | IEEE Jsol Sta Circ2003，38，10： | 1 |
| 15 | A sub-l-V 15-ppm/℃ CMOS bandgap voltage reference without requiring low threshold voltage device显示文摘 | Ka Nang Leung Mok Philip K T | 2002 | IEEE J Solid-State Circuites2002，37，4： | 1 |
| 16 | New criterion for internal crack fomlation in continuously cast steels显示文摘 | Mok W Y Jung Y T Jin S D | 2000 | Metallurgical and Materials Transactions B2000，31，8： | 1 |
| 17 | Nurse follow-up of pa- tients with diabetes: randomized controlled trial显示文摘 | Wong FK Mok MP Chan T | 2005 | Jour- nal Advanced Nursing2005，50，4： | 1 |
| 18 | First-line crizotinib versus chemotherapy in ALK-positive lung cancer 显示文摘 | Solomon BJ Mok T Kim DW | 2014 | N Engl J Med2014，371，23： | 1 |
| 19 | A capacitor-free CMOS low dropout regulator with damping factor control frequency compensation 显示文摘 | LEUNG K N MOK P K T | 2003 | IEEE J Sol Sta Circ2003，38，11： | 1 |
| 20 | Gefitinib or carboplatin --paclitaxel in pulmonary adenocarcinoma显示文摘 | Mok T S Wu Y L Thongprasert S | 2009 | N Engl J Med2009，361，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员